Drugmakers are pushing back against US President Joe Biden’s show of support for waiving patents of Covid-19 vaccines.<br /><br />Research-based pharmaceutical companies say such a move could disrupt a fragile supply chain… and that rich countries should instead share more with the developing world.<br /><br />The International Federation of Pharmaceutical Manufacturers and Associations on Thursday said waiving intellectual property rights for Covid-19 vaccines would invite new manufacturers that lack essential know-how to crowd out established contractors.
